What You Should Know:
– Nanox, the innovative medical imaging company, today announced the acquisition of Zebra Medical Vision, the deep-learning medical imaging analytics company.
– In a deal valued at up to $200M, the medical imaging pioneers will leverage Zebra-Med’s industry-leading team, cutting-edge AI technology, and cloud capabilities, and unprecedented regulatory framework to form the next-generation Medtech juggernaut.
– Nanox also announced today that it has entered into a binding letter of intent to acquire USARAD and its affiliated company, Medical Diagnostics Web.
Acquisition Impact for Zebra Medical
Nanox’s acquisition of Zebra Medical Vision is anticipated to fuel both companies’ shared goal of forming the next generation of AI-enabled hardware and software devices, which is expected to set a new standard in the medical devices sector. With these acquisitions, Nanox will be in the position to gear up towards addressing three major international shortages on a global scale: the shortage of medical imaging devices, radiologists, and connectivity between countries and societies in analyzing medical data. Nanox will be in the position to offer a new model of Management of Medical Service Organizations (MSO), in which Nanox is expected to manage various new critical functions and capabilities, including medical billing with meaningful revenue potential, quality assurance, compliance, and eliminate reliance on third parties for these services.
“Zebra Medical Vision has always operated with the goal of expanding the use of AI in medical imaging to improve health outcomes for patients worldwide,” says Zohar Elhanani, CEO of Zebra Medical Vision. “A trusted, innovative, partner like Nanox can boost our capabilities while sharing our vision for AI which we believe can be best served through the combination of a groundbreaking imaging equipment technology, AI solutions, delivered over state of the art cloud infrastructure. Screening populations to detect and treat chronic disease early on, while establishing new care pathways, has significantly improved treatment outcomes. We are thrilled to be taking the helm of the population health transformation in healthcare.”
